Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History

Chronic Obstructive Pulmonary Disease II: Emphysema

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation

Pulmonary Function Tests

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Residual Volume Responsiveness Testing May Improve the Detection of Reversible Airway Obstruction in Asthma.

The journal of allergy and clinical immunology. In practice·2021

Same author

Air Trapping Correlates With Increased Frequency of Albuterol Use and Severity of Wheeze in Persistent Asthma.

Respiratory care·2020

Same author

Genome-wide interaction study of smoking behavior and non-small cell lung cancer risk in Caucasian population.

Carcinogenesis·2017

Same author

Epigenomic study identifies a novel mesenchyme homeobox2-GLI1 transcription axis involved in cancer drug resistance, overall survival and therapy prognosis in lung cancer patients.

Oncotarget·2017

Same author

Common <i>TDP1</i> Polymorphisms in Relation to Survival among Small Cell Lung Cancer Patients: A Multicenter Study from the International Lung Cancer Consortium.

Clinical cancer research : an official journal of the American Association for Cancer Research·2017

Same author

Pleiotropy of genetic variants on obesity and smoking phenotypes: Results from the Oncoarray Project of The International Lung Cancer Consortium.

PloS one·2017

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Patterns of pulmonary dysfunction in asbestos workers: a cross-sectional study.

Belayneh A Abejie¹, Xiaorong Wang, Stefanos N Kales

¹Harvard School of Public Health, Boston, MA, USA. dchris@hsph.harvard.edu.

Journal of Occupational Medicine and Toxicology (London, England)

|June 8, 2010

Summary

Asbestos exposure significantly reduces lung function, particularly vital capacity (FVC) and diffusing capacity (DLCO), especially with asbestosis. It does not significantly impact the FEV1/FVC ratio alone.

More Related Videos

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Related Experiment Videos

Last Updated: Jun 12, 2026

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Refined Murine Model of Idiopathic Pulmonary Fibrosis

Published on: June 17, 2025

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Area of Science:

Occupational Medicine
Pulmonary Medicine
Toxicology

Background:

Asbestos exposure is known to cause restrictive lung disease.
The link between asbestos and obstructive lung disease is less clear.

Purpose of the Study:

To investigate the impact of asbestos exposure on various lung function parameters.
To differentiate effects of asbestos exposure from smoking in workers.

Main Methods:

Pulmonary function tests (spirometry, DLCO) were conducted on 277 asbestos-exposed workers and 177 controls.
Exposure history and smoking status were collected via questionnaire.
Chest X-rays (CXRs) were evaluated for pneumoconiosis.

Main Results:

Asbestos-exposed workers showed reduced FVC, FEV1, FEV1/FVC, and DLCO compared to controls.
Radiographic asbestosis correlated with lower FVC and DLCO.
Smoking asbestos workers had significantly lower DLCO than non-smoking workers.

Conclusions:

Asbestos exposure, particularly with radiographic asbestosis, impairs FVC, FEV1, and DLCO.
Asbestos exposure alone is not significantly linked to reduced FEV1/FVC.
Further research is needed on asbestos-smoking interactions and asbestos-induced airway dysfunction.